Beyond rankings, Zhejiang University has increasingly been viewed as a key innovation powerhouse in China’s sprawling science and technology ecosystem.
A one-million-tonne-class HMF production facility in Zhejiang was structurally completed in December, laying groundwork for potential scaling of plant-based plastics.
Cannabinoid compounds are known to be effective in treating conditions such as chronic pain, anxiety and epilepsy, but their clinical use has been constrained by risks of addiction and other side effects.
Heart failure affects more than 64 million people globally, and severe cases still carry a five-year mortality rate approaching 50% despite standard therapies.
The initiative is part of a broader push by Zhejiang University of Technology to strengthen international partnerships and link academic research with industrial applications.